Literature DB >> 22659187

The protease-activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression.

Dimitris E Zampatis1, Claudia Rutz, Jens Furkert, Antje Schmidt, Doreen Wüstenhagen, Stefan Kubick, Nikos E Tsopanoglou, Ralf Schülein.   

Abstract

The protease-activated receptor 1 (PAR1) is activated by thrombin cleavage releasing the physiologically-relevant parstatin peptide (residues 1-41). However, the actual length of parstatin was unclear since the receptor may also possess a cleavable signal peptide (residues 1-21) according to prediction programs. Here, we show that this putative signal peptide is indeed functional and removed from the PAR1 resolving the question of parstatin length. Moreover, we show that the sequence encoding the signal peptide may surprisingly play a role in stabilization of the PAR1 mRNA, a function which would be novel for a G protein-coupled receptor.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659187     DOI: 10.1016/j.febslet.2012.05.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  The specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum.

Authors:  Anke Teichmann; Arthur Gibert; André Lampe; Paul Grzesik; Claudia Rutz; Jens Furkert; Jan Schmoranzer; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

2.  The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression.

Authors:  Yunjun Ge; Dehua Yang; Antao Dai; Caihong Zhou; Yue Zhu; Ming-Wei Wang
Journal:  Biosci Rep       Date:  2014-11-21       Impact factor: 3.840

3.  Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets.

Authors:  Shauna L French; Antonia C Paramitha; Mitchell J Moon; Ross A Dickins; Justin R Hamilton
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

4.  Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway.

Authors:  Wolfgang Klein; Claudia Rutz; Jamina Eckhard; Becky Provinciael; Edgar Specker; Martin Neuenschwander; Gunnar Kleinau; Patrick Scheerer; Jens-Peter von Kries; Marc Nazaré; Kurt Vermeire; Ralf Schülein
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

Review 5.  Role of Thrombin in Central Nervous System Injury and Disease.

Authors:  Nathan A Shlobin; Meirav Har-Even; Ze'ev Itsekson-Hayosh; Sagi Harnof; Chaim G Pick
Journal:  Biomolecules       Date:  2021-04-12

6.  A cleavable N-terminal signal peptide promotes widespread olfactory receptor surface expression in HEK293T cells.

Authors:  Blythe D Shepard; Niranjana Natarajan; Ryan J Protzko; Omar W Acres; Jennifer L Pluznick
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

Review 7.  Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems.

Authors:  Anne Zemella; Lena Thoring; Christian Hoffmeister; Stefan Kubick
Journal:  Chembiochem       Date:  2015-10-19       Impact factor: 3.461

8.  High-yield cell-free synthesis of human EGFR by IRES-mediated protein translation in a continuous exchange cell-free reaction format.

Authors:  Robert B Quast; Andrei Sonnabend; Marlitt Stech; Doreen A Wüstenhagen; Stefan Kubick
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

9.  Signal Sequence-Dependent Orientation of Signal Peptide Fragments to Exosomes.

Authors:  Kenji Ono; Mikio Niwa; Hiromi Suzuki; Nahoko Bailey Kobayashi; Tetsuhiko Yoshida; Makoto Sawada
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.